Last reviewed · How we verify
Cosamin DS®
Cosamin DS provides glucosamine and chondroitin sulfate to support cartilage structure and reduce joint degradation in osteoarthritis.
Cosamin DS provides glucosamine and chondroitin sulfate to support cartilage structure and reduce joint degradation in osteoarthritis. Used for Osteoarthritis pain and joint function.
At a glance
| Generic name | Cosamin DS® |
|---|---|
| Sponsor | Ache Laboratorios Farmaceuticos S.A. |
| Drug class | Nutraceutical/Dietary supplement |
| Modality | Small molecule |
| Therapeutic area | Rheumatology/Orthopedics |
| Phase | Phase 3 |
Mechanism of action
Glucosamine is a precursor for glycosaminoglycan synthesis, which helps maintain cartilage matrix integrity and may reduce cartilage breakdown. Chondroitin sulfate is a structural component of cartilage that may help retain water and resist compression. Together, these agents are thought to slow osteoarthritic progression and provide symptomatic relief.
Approved indications
- Osteoarthritis pain and joint function
Common side effects
- Gastrointestinal upset
- Nausea
- Headache
Key clinical trials
- Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee (PHASE3)
- Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cosamin DS® CI brief — competitive landscape report
- Cosamin DS® updates RSS · CI watch RSS
- Ache Laboratorios Farmaceuticos S.A. portfolio CI